Ratings by Cantor Fitzgerald (Ross Osborn)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/17/2026 | MiMedx Group | MDXG | Maintain | Overweight (N/A) |
|
Details | ||
| 12/4/2025 | Nano-X Imaging | NNOX | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/11/2025 | Prenetics | PRE | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/10/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/10/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/10/2025 | LeMaitre Vascular | LMAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/6/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/5/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (N/A) |
|
Details | ||
| 9/29/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (Overweight) |
|
Details | ||
| 9/26/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (Overweight) |
|
Details | ||
| 9/22/2025 | Nano-X Imaging | NNOX | Maintain | Overweight (Overweight) |
|
Details | ||
| 9/9/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/19/2025 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/11/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/11/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/11/2025 | AxoGen, Inc. | AXGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/11/2025 | LeMaitre Vascular | LMAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/11/2025 | Bioventus Inc | BVS | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/11/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/11/2025 | Nyxoah SA | NYXH | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/31/2025 | MiMedx Group | MDXG | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2025 | Exagen | XGN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/15/2025 | MiMedx Group | MDXG | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/15/2025 | Sanara MedTech | SMTI | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/7/2025 | Bioventus Inc | BVS | New Coverage | Overweight (N/A) |
7.02 (8.51) |
21.23% | Details | |
| 6/25/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/23/2025 | Prenetics | PRE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/16/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/16/2025 | Prenetics | PRE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/13/2025 | Prenetics | PRE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/12/2025 | Prenetics | PRE | Maintain | Overweight (N/A) |
|
Details | ||
| 6/12/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/9/2025 | TriSalus Life Sciences, Inc. | TLSI | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/9/2025 | Nano-X Imaging | NNOX | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/2/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/2/2025 | AxoGen, Inc. | AXGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/2/2025 | Elutia | ELUT | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/2/2025 | TriSalus Life Sciences, Inc. | TLSI | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/27/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/19/2025 | Sanara MedTech | SMTI | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/19/2025 | Nyxoah SA | NYXH | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/19/2025 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/19/2025 | TriSalus Life Sciences, Inc. | TLSI | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/15/2025 | Exagen | XGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/14/2025 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/21/2025 | Anteris Technologies Global | AVR | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/21/2025 | Nano-X Imaging | NNOX | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/14/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/14/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/10/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/8/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/1/2025 | Nano-X Imaging | NNOX | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/26/2025 | Sanara MedTech | SMTI | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/26/2025 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/18/2025 | LeMaitre Vascular | LMAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/18/2025 | Aziyo Biologics Inc. | ELUT | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/18/2025 | AxoGen, Inc. | AXGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/18/2025 | Anteris Technologies Global | AVR | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/18/2025 | Pacific Biosciences of California | PACB | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/18/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/18/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Exagen | XGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | TriSalus Life Sciences, Inc. | TLSI | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Sanara MedTech | SMTI | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Prenetics | PRE | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | PAVmed | PAVM | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/10/2025 | Pacific Biosciences of California | PACB | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Nyxoah SA | NYXH | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Nano-X Imaging | NNOX | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | MiMedx Group | MDXG | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | LeMaitre Vascular | LMAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/10/2025 | Aziyo Biologics Inc. | ELUT | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | AxoGen, Inc. | AXGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Anteris Technologies Global | AVR | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/7/2025 | Aziyo Biologics Inc. | ELUT | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/5/2025 | AxoGen, Inc. | AXGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/5/2025 | NeuroPace Inc | NPCE | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/28/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/28/2025 | Oranogenesis Holdings | ORGO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2025 | AxoGen, Inc. | AXGN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/13/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/5/2025 | CVRx Inc | CVRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/22/2025 | Sanara MedTech | SMTI | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2025 | Anteris Technologies Global | AVR | New Coverage | Overweight (N/A) |
5.61 (6.69) |
19.25% | Details | |
| 12/17/2024 | TriSalus Life Sciences, Inc. | TLSI | New Coverage | Overweight (N/A) |
3.88 (3.77) |
-2.84% | Details | |
| 12/5/2024 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/5/2024 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/5/2024 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/26/2024 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2024 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/13/2024 | Oranogenesis Holdings | ORGO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2024 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/15/2024 | LeMaitre Vascular | LMAT | New Coverage | Neutral (N/A) |
92.14 (91.96) |
-0.2% | Details | |
| 9/10/2024 | CVRx Inc | CVRX | New Coverage | Overweight (N/A) |
7.96 (5.03) |
-36.81% | Details | |
| 8/20/2024 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2024 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2024 | Aspira Women’s Health | AWH | Maintain | Neutral (N/A) |
|
Details | ||
| 7/2/2024 | MiMedx Group | MDXG | New Coverage | Overweight (N/A) |
6.70 (3.60) |
-46.27% | Details | |
| 5/15/2024 | Nyxoah SA | NYXH | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2024 | Exagen | XGN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2024 | Aziyo Biologics Inc. | ELUT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/2/2024 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/26/2024 | Sanara MedTech | SMTI | Maintain | Overweight (N/A) |
|
Details | ||
| 3/26/2024 | Lucid Diagnostics | LUCD | Maintain | Overweight (N/A) |
|
Details | ||
| 3/6/2024 | NeuroPace Inc | NPCE | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2024 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | Pacific Biosciences of California | PACB | Maintain | Overweight (N/A) |
|
Details | ||
| 2/15/2024 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2024 | Nyxoah SA | NYXH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/7/2024 | Oranogenesis Holdings | ORGO | New Coverage | Overweight (N/A) |
3.43 (2.34) |
-31.78% | Details | |
| 11/29/2023 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/21/2023 | Mainz Biomed B.V. | MYNZ | Downgrade | Neutral (Overweight) |
1.16 (0.84) |
-27.59% | Details | |
| 11/16/2023 | Asensus Surgical inc. | ASXC | Downgrade | Neutral (Overweight) |
0.24 (0.35) |
45.83% | Details | |
| 11/15/2023 | Sanara MedTech | SMTI | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2023 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2023 | Aziyo Biologics Inc. | ELUT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2023 | NeuroPace Inc | NPCE | New Coverage | Overweight (N/A) |
7.74 (15.64) |
102.07% | Details | |
| 11/7/2023 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2023 | Pacific Biosciences of California | PACB | Upgrade | Overweight (Neutral) |
7.11 (1.31) |
-81.58% | Details | |
| 9/18/2023 | Prenetics | PRE | Maintain | Overweight (N/A) |
|
Details | ||
| 8/16/2023 | VolitionRX | VNRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/23/2023 | Nano-X Imaging | NNOX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/18/2023 | Nyxoah SA | NYXH | Maintain | Overweight (N/A) |
|
Details | ||
| 5/17/2023 | Mainz Biomed B.V. | MYNZ | Maintain | Overweight (N/A) |
|
Details | ||
| 5/17/2023 | Aspira Women’s Health | AWH | Maintain | Neutral (N/A) |
|
Details | ||
| 5/12/2023 | Aziyo Biologics Inc. | AZYO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2023 | Asensus Surgical inc. | ASXC | Maintain | Overweight (N/A) |
|
Details | ||
| 5/3/2023 | Pacific Biosciences of California | PACB | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2023 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/17/2023 | Prenetics | PRE | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2023 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 1/20/2023 | PAVmed | PAVM | Downgrade | Neutral (Overweight) |
0.46 (5.00) |
986.96% | Details | |
| 1/20/2023 | Aspira Women’s Health | AWH | Downgrade | Neutral (Overweight) |
0.50 (0.08) |
-84% | Details | |
| 1/20/2023 | Pacific Biosciences of California | PACB | Downgrade | Neutral (Buy) |
11.29 (1.31) |
-88.4% | Details | |
| 1/18/2023 | Prenetics | PRE | New Coverage | Overweight (N/A) |
1.53 (21.63) |
1313.73% | Details | |
| 1/5/2023 | Nano-X Imaging | NNOX | New Coverage | Overweight (N/A) |
7.34 (1.76) |
-76.02% | Details | |
| 11/22/2022 | PAVmed | PAVM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2022 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2022 | Nyxoah SA | NYXH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2022 | AxoGen, Inc. | AXGN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2022 | Mainz Biomed B.V. | MYNZ | New Coverage | Overweight (N/A) |
6.63 (1.16) |
-82.5% | Details | |
| 10/11/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (Overweight) |
|
Details | ||
| 9/8/2022 | Asensus Surgical inc. | ASXC | New Coverage | Overweight (N/A) |
0.53 (0.35) |
-33.96% | Details | |
| 8/3/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/15/2022 | Sanara MedTech | SMTI | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/13/2022 | VolitionRX | VNRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/11/2022 | Nyxoah SA | NYXH | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/22/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/8/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/8/2022 | Aspira Women’s Health | AWH | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/2/2022 | Nyxoah SA | NYXH | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/27/2022 | Aziyo Biologics Inc. | AZYO | New Coverage | Overweight (Overweight) |
5.88 (1.49) |
-74.66% | Details | |
| 5/20/2022 | Sanara MedTech | SMTI | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/18/2022 | VolitionRX | VNRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/18/2022 | Exagen | XGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/13/2022 | PAVmed | PAVM | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/4/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/28/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/27/2022 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/26/2022 | VolitionRX | VNRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/7/2022 | SI-BONE Inc. | SIBN | New Coverage | Overweight (N/A) |
21.28 (15.42) |
-27.54% | Details | |
| 4/4/2022 | Pacific Biosciences of California | PACB | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/30/2022 | PAVmed | PAVM | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/29/2022 | Lucid Diagnostics Inc | LUCD | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/23/2022 | Aspira Women’s Health | AWH | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/23/2022 | Exagen | XGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/11/2022 | AxoGen, Inc. | AXGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/11/2022 | AxoGen, Inc. | AXGN | New Coverage | Overweight (N/A) |
8.51 (43.00) |
405.29% | Details | |
| 1/21/2022 | Pacific Biosciences of California | PACB | New Coverage | Overweight (N/A) |
10.39 (1.31) |
-87.39% | Details | |
| 1/12/2022 | Aspira Women’s Health | AWH | New Coverage | Overweight (N/A) |
1.47 (0.08) |
-94.56% | Details | |
| 12/21/2021 | Nyxoah SA | NYXH | New Coverage | Overweight (N/A) |
19.73 (1.39) |
-92.95% | Details |
